Analyst Ratings For Quest Diagnostics (NYSE:DGX)
Today, Barclays PLC reiterated its Hold rating on Quest Diagnostics (NYSE:DGX) with a price target of $110.00.
There are 7 hold ratings, 5 buy ratings, 1 strong buy rating on the stock.
The current consensus rating on Quest Diagnostics (NYSE:DGX) is Buy (Score: 2.54) with a consensus target price of $108.65 per share, a potential 0.87% downside.
Some recent analyst ratings include
- 7/19/2017-Barclays PLC Reiterated Rating of Hold.
- 7/13/2017-Credit Suisse Group Reiterated Rating of Neutral.
- 6/28/2017-Evercore ISI Reiterated Rating of In-Line.
- 6/13/2017-Canaccord Genuity Reiterated Rating of Buy.
- 5/28/2017-Bank of America Corporation Reiterated Rating of Neutral.
- 5/12/2017-Argus initiated coverage with a Hold rating.
Dividend information for Quest Diagnostics (NYSE:DGX)
Quest Diagnostics (NYSE:DGX) pays an annual dividend of Community Ranking: with a yield of 1.64% and an average dividend growth of 9.60% based on a 3 Year Average.
Dividend History for Quest Diagnostics (NYSE:DGX)
- On 5/16/2017 Quest Diagnostics announced a quarterly dividend of $0.45 1.71% with an ex dividend date of 7/6/2017 which will be payable on 7/24/2017.
- On 2/21/2017 Quest Diagnostics announced a quarterly dividend of $0.45 1.88% with an ex dividend date of 4/3/2017 which will be payable on 4/19/2017.
- On 11/11/2016 Quest Diagnostics announced a quarterly dividend of $0.45 with an ex dividend date of 1/6/2017 which will be payable on 1/25/2017.
- On 8/17/2016 Quest Diagnostics announced a quarterly dividend of $0.40 1.88% with an ex dividend date of 9/30/2016 which will be payable on 10/19/2016.
- On 5/18/2016 Quest Diagnostics announced a quarterly dividend of $0.40 2.1% with an ex dividend date of 7/1/2016 which will be payable on 7/20/2016.
- On 1/28/2016 Quest Diagnostics announced a quarterly dividend of $0.40 2.31% with an ex dividend date of 4/4/2016 which will be payable on 4/20/2016.
- On 12/4/2015 Quest Diagnostics announced a quarterly dividend of $0.38 2.22% with an ex dividend date of 1/8/2016 which will be payable on 1/27/2016.
Recent Insider Trading Activity For Quest Diagnostics (NYSE:DGX)
Quest Diagnostics (NYSE:DGX) has insider ownership of 1.50% and institutional ownership of 90.65%.
- On 6/19/2017 Catherine T Doherty, SVP, sold 59,762 with an average share price of $107.55 per share and the total transaction amounting to $6,427,403.10. View SEC Filing
- On 4/24/2017 Jenne K Britell, Director, sold 6,111 with an average share price of $104.03 per share and the total transaction amounting to $635,727.33. View SEC Filing
- On 4/20/2017 Michael E Prevoznik, SVP, sold 29,513 with an average share price of $100.00 per share and the total transaction amounting to $2,951,300.00. View SEC Filing
- On 3/16/2017 Michael E Prevoznik, SVP, sold 13,987 with an average share price of $100.00 per share and the total transaction amounting to $1,398,700.00. View SEC Filing
- On 3/3/2017 Catherine T Doherty, SVP, sold 7,162 with an average share price of $98.28 per share and the total transaction amounting to $703,881.36. View SEC Filing
- On 2/27/2017 Michael E Prevoznik, SVP, sold 440 with an average share price of $97.39 per share and the total transaction amounting to $42,851.60. View SEC Filing
- On 1/30/2017 Catherine T Doherty, SVP, sold 80,000 with an average share price of $90.58 per share and the total transaction amounting to $7,246,400.00. View SEC Filing
Recent Trading Activity for Quest Diagnostics (NYSE:DGX)
Shares of Quest Diagnostics closed the previous trading session at 109.61 down -0.05 -0.05% with 795,966 shares trading hands.